Gut microbiota and intestinal immunity-A crosstalk in irritable bowel syndrome

Immunology. 2024 Jan 4. doi: 10.1111/imm.13749. Online ahead of print.ABSTRACTIrritable bowel syndrome (IBS), one of the most prevalent functional gastrointestinal disorders, is characterized by recurrent abdominal pain and abnormal defecation habits, resulting in a severe healthcare burden worldwide. The pathophysiological mechanisms of IBS are multi-factorially involved, including food antigens, visceral hypersensitivity reactions, and the brain-gut axis. Numerous studies have found that gut microbiota and intestinal mucosal immunity play an important role in the development of IBS in crosstalk with multiple mechanisms. Therefore, based on existing evidence, this paper elaborates that the damage and activation of intestinal mucosal immunity and the disturbance of gut microbiota are closely related to the progression of IBS. Combined with the application prospect, it also provides references for further in-depth exploration and clinical practice.PMID:38174581 | DOI:10.1111/imm.13749
Source: Immunology - Category: Allergy & Immunology Authors: Source Type: research